RNA biology is rapidly transforming our understanding of cancer pathogenesis, diagnostics, and therapeutics. To capitalize on this paradigm shift and foster a collaborative scientific community, the RTICC issued a call for proposals uniting researchers from life sciences, medicine, chemical engineering, and exact sciences to broadly advance high-impact RNA research in cancer.

We are proud to announce the selected collaborative projects and congratulate the winning Principal Investigators from across Technion faculties:

Prof. Yael Mandel-Gutfeund, (Faculty of Biology) & Asst. Prof. Gilad Barshad, (Rappaport Faculty of Medicine):
"Studying the role of the putative DNA and RNA binding protein RBM25 as a transcription regulator of cell cycle and proliferation and its miss-regulation in cancer”.

Prof. Nabieh Ayoub (Faculty of Biology) & Asst. Prof. Dan Bracha (Faculty of Biotechnology and Food Engineering) :
"Deciphering how RNA-dependent RBM15 condensates drive replication stress and genome instability in cancer”.

Prof. Marcelle Machluf (Faculty of Biotechnology and Food Engineering) & Asst. Prof. Assaf Zinger (Faculty of Chemical Engineering) :
"LNP-NG Hybrid Vesicle Platform for Targeted mRNA Delivery to Solid Tumors”.

Prof. Yonatan Savir (Rappaport Faculty of Medicine) & Prof. Ayelet Lamm (Faculty of Biology):
"Using Embryonic Development to Discover RNA Editing Programs Driving Cancer Cell Plasticity”.

Assoc. Prof. Ayala Shiber (Faculty of Biology) & Prof. Mordechai Choder (Rappaport Faculty of Medicine):
"Co-transcriptional Hsp70 imprinting as a personal-chaperone mechanism for protein folding and complex assembly”.

Asst. Prof. Boris Slobodin (Faculty of Medicine) & Asst. Prof. Assaf Bester (Faculty of Biology):
"Uncovering the cytoplasmic roles of IncRNAs in DNA damage”.